Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CHINOOK THERAPEUTICS, INC. (KDNY)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -59.1% | -43.9% | -77.8% | -22.7% | -49.8% | -36.8% | -32.9% | -11.3% |
| ROIC (including intangibles) | -45.8% | -26.7% | -24.1% | -752.8% | -46.7% | -37.3% | -27.9% | -4.4% |
| ROE | -42.9% | -20.7% | -16.4% | 93.8% | -71.4% | -39.9% | -41.4% | -5.2% |
| ROA | -33.0% | -16.6% | -12.8% | -127.0% | -27.0% | -21.3% | -21.4% | -2.8% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 0.0 | 0.0 | 0.0 | | 291.2 | 20.9 | 8.2 | 24.2 |
| Days payables outstanding | 296.9 | 155.9 | 965.7 | | | | | |
| Cash conversion cycle | -296.9 | -155.9 | -965.7 | | | | | |
|